Skip to content
Trending storyDeveloping

DNA-PK sustains the S/G2 checkpoint in ATM-deficient cells, blunting ATR inhibitors

1 report1 sourceupdated 13 hours ago

Start here

Synthesis

A preprint study posted to bioRxiv on 28 October 2026 shows that DNA-PK maintains the S/G2 checkpoint in cells lacking ATM function, compensating for the loss of ATM and limiting how well ATR inhibitors work. After ATR inhibition, both DNA-PK and ATM are activated at the S/G2 boundary; without ATM, DNA-PK additionally senses aberrant replication structures during S phase, allowing cells to tolerate ATR inhibition. Blocking ATR and DNA-PK together proved synergistic in ATM-deficient cells and improved efficacy in ATM-deficient patient-derived xenograft models. The findings support clinical evaluation of combined ATR and DNA-PK inhibition in ATM-deficient cancers. What remains open is translating the combination into patients: trial design, dosing and patient selection for ATM-deficient tumors have yet to be worked out.

Written by a model from the reports · updated 3 hours ago

Coverage timeline

Follow the coverage to see the different angles.

Oct 28
  1. biorxiv.orgPick
    DNA-PK enforces the S/G2 checkpoint in ATM-deficient cells to limit ATR inhibitor efficacy

    A study shows that DNA-PK maintains the S/G2 checkpoint in ATM-deficient cells and compensates for loss of ATM function, limiting ATR inhibitor efficacy. After ATR inhibition, DNA-PK and ATM are activated at the S/G2 boundary; when ATM is absent, DNA-PK also detects aberrant replication structures in S phase, allowing cells to tolerate ATR inhibition. Combined ATR and DNA-PK inhibition is synergistic in ATM-deficient cells and enhances efficacy in ATM-deficient PDX models, supporting clinical evaluation in ATM-deficient cancers.

Heat trend for this story

Heat now 7·Peak in the comparable set 10 (Oct 28 08:00)·Change over 24h in the comparable set –·Participants now 1

Participants counted1
00.250.50.751
Heat over time
02.557.510Oct28Oct28Oct28Oct28

Participants counted above, heat below. The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's reading; the left and right arrow keys work too.

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.